Showing 1 - 20 results of 32 for search 'I. Yu', query time: 0.04s
Refine Results
-
1
Screening investigation of patients with diffuse liver diseases by I. Yu. Pirogova
Published 2010-06-01
Article -
2
Gastric Polyps and Atrophic Gastritis by I. Yu. Kolesnikova, A. S. Novikova
Published 2021-06-01
Article -
3
Complex application of mathematical methods in diagnostics of diffuse liver diseases by I. Yu. Pirogova, S. A. Pyshkin, A. A. Bolotov
Published 2011-02-01
Article -
4
-
5
-
6
Systemic immune response at gastroesophageal reflux disease by Yu. V. Yevsyutina, A. S. Trukhmanov, V. T. Ivashkin, S. V. Lyamina, I. Yu. Malyshev
Published 2015-10-01
Article -
7
-
8
-
9
-
10
Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19 by I. Yu. Feklina, M. G. Mnatsakanyan, A. P. Pogromov, O. V. Tashchyаn
Published 2022-03-01
Article -
11
-
12
-
13
Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association by V. T. Ivashkin, M. V. Mayevskaya, Ch. S. Pavlov, Ye. A. Fedosyina, Ye. N. Bessonova, I. Yu. Pirogova, D. V. Garbuzenko
Published 2018-08-01
Article -
14
An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH S... by M. V. Mayevskaya, M. Yu. Nadinskaia, V. D. Lunkov, I. Yu. Pirogova, E. V. Chesnokov, Kh. B. Kodzoeva, V. T. Ivashkin
Published 2020-01-01
Article -
15
Hereditary colorectal cancer: genetics and screening diagnostics by O. I. Kit, D. I. Vodolazhsky, Yu. A. Gevorkyan, N. V. Soldatkina, F. N. Grechkin, M. A. Kozhushko, I. Yu. Yefimova
Published 2018-08-01
Article -
16
Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by M. V. Mayevskaya, V. T. Ivashkin, V. D. Lunkov, S. P. Kryzhanovskiy, I. Yu. Pirogova, Ch. S. Pavlov, M. S. Zharkova, A. G. Beniashvili, M. A. Morozova
Published 2018-11-01
Article -
17
Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs by Ye. N. German, M. V. Mayevskaya, O. I. Andreytseva, V. T. Ivashkin, A. V. Chzhao, A. G. Serova, G. V. Mikhaylovskaya, I. Yu. Pirogova
Published 2011-03-01
Article -
18
-
19
Macrophage phenotype after human refluxate exposure, esophageal dysmotility and their correlation with gastroesophageal reflux disease by A. V. Paraskevova, A. S. Trukhmanov, O. A. Storonova, S. V. Lyamina, S. V. Kalish, S. S. Pirogov, A. B. Ponomarev, D. E. Rumyantseva, I. Yu. Malyshev, I. V. Maev, V. T. Ivashkin
Published 2022-05-01
Article -
20
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial) by Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin
Published 2018-08-01
Article